Skip to main content
Log in

A novel mutation in the N-terminal region of the CYP17A1 gene in a patient with 17α-hydroxylase/17,20-lyase deficiency

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The deficiency of 17α-hydroxylase/17,20-lyase causes a rare autosomal recessive disorder presenting with congenital adrenal insufficiency (CAH) and sexual infantilism. Both 17α-hydroxylase and 17,20-lyase reactions are catalyzed by a single polypeptide, cytochrome P450c17 (CYP17), which is encoded by the CYP17A1 gene. We describe the clinical, hormonal, and molecular findings of a 33-yr-old patient presenting with primary amenhorrea, late onset hypertension, and hypokalemic myopathy. The molecular analysis of CYP17A1 revealed a novel homozygous missense mutation resulting in the substitution of arginine to lysine at the amino acid position 21 (p.R21L).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Biglieri EG, Herron MA, Brust N. 17-hydroxylation deficiency in man. J Clin Invest 1966, 45: 1946–54.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  2. New MI. Male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency. J Clin Invest 1970, 49: 1930–41.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  3. Bricaire H, Luton JP, Laudat P, et al. A new male pseudohermaphroditism associated with hypertension due to a block of 17-hydroxylation. J Clin Endocrinol Metab 1972, 35: 67–72.

    Article  PubMed  CAS  Google Scholar 

  4. Yanase T, Simpson ER, Waterman MR. 17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 1991, 12: 91–108.

    Article  PubMed  CAS  Google Scholar 

  5. Geller DH, Auchus RJ, Mendonca BB, Miller WL. The genetic and functional basis of isolated 17,20-lyase deficiency. Nat Genet 1997, 17: 201–5.

    Article  PubMed  CAS  Google Scholar 

  6. Costa-Santos M, Kater CE, Auchus RJ. Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. J Clin Endocrinol Metab 2004, 89: 49–60.

    Article  PubMed  CAS  Google Scholar 

  7. Satoh J, Kuroda Y, Nawata H, Yanase T. Molecular basis of hypokalemic myopathy caused by 17alpha-hydroxylase/17,20-lyase deficiency. Neurology 1998, 51: 1748–51.

    Article  PubMed  CAS  Google Scholar 

  8. Kater CE, Biglieri EG. Disorders of steroid 17 alpha-hydroxylase deficiency. Endocrinol Metab Clin North Am 1994, 23: 341–57.

    PubMed  CAS  Google Scholar 

  9. Moreira AC, Leal AM, Castro M. Characterization of adrenocorticotropin secretion in a patient with 17 alpha-hydroxylase deficiency. J Clin Endocrinol Metab 1990, 71: 86–91.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Nuzzo MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nuzzo, V., Tauchmanova, L., Brunetti-Pierri, R. et al. A novel mutation in the N-terminal region of the CYP17A1 gene in a patient with 17α-hydroxylase/17,20-lyase deficiency. J Endocrinol Invest 32, 322–324 (2009). https://doi.org/10.1007/BF03345720

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345720

Key-words

Navigation